EBS

SEC source: 0001367644-23-000123 · wk-form4_1686705732.xml · derivative · entry 3

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,169

Underlying: Common Stock · 49,231 shares

Expires 2030-06-08

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-23-000123 · wk-form4_1686705732.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,206

F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-23-000123 · wk-form4_1686705732.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,975

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000122 · wk-form4_1686705705.xml · derivative · entry 3

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,944

Underlying: Common Stock · 49,231 shares

Expires 2030-06-08

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

F4 · balance_after: Represents the corrected number of securities owned due to a computational error in prior Form-4s

SEC source: 0001367644-23-000122 · wk-form4_1686705705.xml · nonDerivative · entry 2

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,992

F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-23-000122 · wk-form4_1686705705.xml · nonDerivative · entry 1

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,761

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000125 · wk-form4_1686705775.xml · derivative · entry 3

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,614

Underlying: Common Stock · 9,231 shares

Expires 2030-06-08

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

F4 · balance_after: Represents the corrected number of securities owned due to a computational error in prior Form-4s

SEC source: 0001367644-23-000125 · wk-form4_1686705775.xml · nonDerivative · entry 2

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,225

F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-23-000125 · wk-form4_1686705775.xml · nonDerivative · entry 1

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,994

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000124 · wk-form4_1686705752.xml · derivative · entry 3

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,113

Underlying: Common Stock · 30,770 shares

Expires 2030-06-08

F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-23-000124 · wk-form4_1686705752.xml · nonDerivative · entry 2

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,349

F3 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

F2 · balance_after: Represents the corrected number of securities owned due to a computational error in prior Form-4s

SEC source: 0001367644-23-000124 · wk-form4_1686705752.xml · nonDerivative · entry 1

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,579

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

F2 · balance_after: Represents the corrected number of securities owned due to a computational error in prior Form-4s

SEC source: 0001367644-23-000121 · wk-form4_1686705651.xml · derivative · entry 3

Havey Adam · CIK 0001514588 · EVP, Business Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,906

Underlying: Common Stock · 49,231 shares

Expires 2030-06-08

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-23-000121 · wk-form4_1686705651.xml · nonDerivative · entry 2

Havey Adam · CIK 0001514588 · EVP, Business Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,398

F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-23-000121 · wk-form4_1686705651.xml · nonDerivative · entry 1

Havey Adam · CIK 0001514588 · EVP, Business Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,167

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000119 · wk-form4_1686705615.xml · derivative · entry 3

Kramer Robert · CIK 0001380956 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 535,051

Underlying: Common Stock · 141,539 shares

Expires 2030-06-08

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

F4 · balance_after: Represents the corrected number of securities owned due to a computational error in prior Form-4s

SEC source: 0001367644-23-000119 · wk-form4_1686705615.xml · nonDerivative · entry 2

Kramer Robert · CIK 0001380956 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 506,059

F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-23-000119 · wk-form4_1686705615.xml · nonDerivative · entry 1

Kramer Robert · CIK 0001380956 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364,520

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000137 · wk-form4_1690201708.xml · nonDerivative · entry 2

Zoon Kathryn C · CIK 0001685720 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,971

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Zoon.

SEC source: 0001367644-23-000110 · wk-form4_1685488183.xml · nonDerivative · entry 1

Zoon Kathryn C · CIK 0001685720 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,501

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000109 · wk-form4_1685488148.xml · nonDerivative · entry 1

White Marvin L · CIK 0001493324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,949

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000108 · wk-form4_1685488079.xml · nonDerivative · entry 1

Hauer Jerome M · CIK 0001294935 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,508

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000107 · wk-form4_1685488014.xml · nonDerivative · entry 1

SULLIVAN LOUIS W · CIK 0001193522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,265

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000105 · wk-form4_1685487901.xml · nonDerivative · entry 1

Katkin Keith · CIK 0001314596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,442

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000106 · wk-form4_1685487966.xml · nonDerivative · entry 1

Richard Ronald · CIK 0001380177 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,684

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000104 · wk-form4_1685487864.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,899

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000103 · wk-form4_1685487805.xml · nonDerivative · entry 1

Dayal Sujata Tyagi · CIK 0001536908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,699

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one annual installment on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000137 · wk-form4_1690201708.xml · nonDerivative · entry 1

Zoon Kathryn C · CIK 0001685720 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,801

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Zoon.

SEC source: 0001367644-23-000080 · wf-form4_168117008804282.xml · nonDerivative · entry 1

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,154

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000067 · wf-form4_167814934737010.xml · derivative · entry 3

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,938

Underlying: Common Stock · 12,308 shares

Expires 2030-03-01

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

F4 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000067 · wf-form4_167814934737010.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,359

F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-23-000067 · wf-form4_167814934737010.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,051

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000068 · wf-form4_167814936251398.xml · derivative · entry 3

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,049

Underlying: Common Stock · 12,308 shares

Expires 2030-03-01

F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

F2 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000068 · wf-form4_167814936251398.xml · nonDerivative · entry 2

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,145

F3 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

F2 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000068 · wf-form4_167814936251398.xml · nonDerivative · entry 1

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,837

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

F2 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000072 · wf-form4_167814943048288.xml · derivative · entry 3

Havey Adam · CIK 0001514588 · EVP, Business Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,675

Underlying: Common Stock · 12,308 shares

Expires 2030-03-01

F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company.

F2 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000072 · wf-form4_167814943048288.xml · nonDerivative · entry 2

Havey Adam · CIK 0001514588 · EVP, Business Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,551

F3 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

F2 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000072 · wf-form4_167814943048288.xml · nonDerivative · entry 1

Havey Adam · CIK 0001514588 · EVP, Business Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,243

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

F2 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000071 · wf-form4_167814941740129.xml · derivative · entry 3

Kramer Robert · CIK 0001380956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,182

Underlying: Common Stock · 38,462 shares

Expires 2030-03-01

F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

F2 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000071 · wf-form4_167814941740129.xml · nonDerivative · entry 2

Kramer Robert · CIK 0001380956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,751

F3 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

F2 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000071 · wf-form4_167814941740129.xml · nonDerivative · entry 1

Kramer Robert · CIK 0001380956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,289

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

F2 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000070 · wf-form4_167814940093617.xml · derivative · entry 3

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,343

Underlying: Common Stock · 7,692 shares

Expires 2030-03-01

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

F4 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000070 · wf-form4_167814940093617.xml · nonDerivative · entry 2

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,674

F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-23-000070 · wf-form4_167814940093617.xml · nonDerivative · entry 1

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,982

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in two equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000069 · wf-form4_167814938664720.xml · derivative · entry 3

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,459

Underlying: Common Stock · 2,308 shares

Expires 2030-03-01

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

F4 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000069 · wf-form4_167814938664720.xml · nonDerivative · entry 2

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,378

F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-23-000069 · wf-form4_167814938664720.xml · nonDerivative · entry 1

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,070

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000060 · wf-form4_167778621301638.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,897

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000056 · wf-form4_167778612811435.xml · nonDerivative · entry 1

Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,824

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000057 · wf-form4_167778614592939.xml · nonDerivative · entry 1

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,906

F1 · shares: Represents shares of common stock withheld to pay taxes.